Hartley-Brown MA - Search Results

1

Kidney transplantation in patients with multiple myeloma: narrative analysis and review of the last two decades.

Chitty DW, Hartley-Brown MA, Abate M, Thakur R, Wanchoo R, Jhaveri KD, Nair V. Chitty DW, et al. Among authors: hartley brown ma. Nephrol Dial Transplant. 2022 Aug 22;37(9):1616-1626. doi: 10.1093/ndt/gfaa361. Nephrol Dial Transplant. 2022. PMID: 33295615 Review.

2

Monoclonal Antibodies in Myeloma: Optimizing Targeted Therapy.

Hartley-Brown M, Chitty D, Thakur R. Hartley-Brown M, et al. Cancer J. 2021 May-Jun 01;27(3):222-230. doi: 10.1097/PPO.0000000000000521. Cancer J. 2021. PMID: 34549911 Review.

3

Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-2019.

Cotte C, Hartley-Brown M. Cotte C, et al. Curr Probl Cancer. 2022 Jun;46(3):100831. doi: 10.1016/j.currproblcancer.2021.100831. Epub 2022 Jan 10. Curr Probl Cancer. 2022. PMID: 35091270

4

Multiple Myeloma in a Young Female Presenting with Neurological Symptoms.

Lee M, Zhang X, Nguyen V, Hartley-Brown M. Lee M, et al. Case Rep Hematol. 2020 Feb 13;2020:1375174. doi: 10.1155/2020/1375174. eCollection 2020. Case Rep Hematol. 2020. PMID: 32099696 Free PMC article.

5

Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients.

Remily-Wood ER, Benson K, Baz RC, Chen YA, Hussein M, Hartley-Brown MA, Sprung RW, Perez B, Liu RZ, Yoder SJ, Teer JK, Eschrich SA, Koomen JM. Remily-Wood ER, et al. Among authors: hartley brown ma. Proteomics Clin Appl. 2014 Oct;8(9-10):783-95. doi: 10.1002/prca.201300077. Epub 2014 Sep 15. Proteomics Clin Appl. 2014. PMID: 24723328 Free PMC article.

6

A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma.

Midha S, Hartley-Brown MA, Mo CC, Hossain S, Nadeem O, O'Donnell EK, Bianchi G, Sperling AS, Laubach JP, Richardson PG. Midha S, et al. Among authors: hartley brown ma. Expert Opin Drug Saf. 2023 Jul-Dec;22(11):1049-1071. doi: 10.1080/14740338.2023.2274420. Epub 2023 Nov 28. Expert Opin Drug Saf. 2023. PMID: 37906232 Review.

7

Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non-Hispanic White race/ethnicity in the United States.

Buck T, Hartley-Brown MA, Efebera YA, Milner CP, Zonder JA, Richardson PG, Salinardi T, Rice MS. Buck T, et al. Among authors: hartley brown ma. Haematologica. 2023 Nov 30. doi: 10.3324/haematol.2023.282788. Online ahead of print. Haematologica. 2023. PMID: 38031762 Free article.

8

Selinexor: Targeting a novel pathway in multiple myeloma.

Mo CC, Yee AJ, Midha S, Hartley-Brown MA, Nadeem O, O'Donnell EK, Bianchi G, Sperling AS, Laubach JP, Richardson PG. Mo CC, et al. Among authors: hartley brown ma. EJHaem. 2023 May 15;4(3):792-810. doi: 10.1002/jha2.709. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601856 Free PMC article. Review.

9

State-of-the-Art Management of Complications of Myeloma and Its Treatment.

Hartley-Brown MA, Sullivan DM, Baz R. Hartley-Brown MA, et al. Adv Hematol. 2010;2010:343089. doi: 10.1155/2010/343089. Epub 2010 Jun 27. Adv Hematol. 2010. PMID: 20671999 Free PMC article.

10

Antibody-drug conjugate therapies in multiple myeloma-what's next on the horizon?

Hartley-Brown M, Richardson P. Hartley-Brown M, et al. Explor Target Antitumor Ther. 2022;3(1):1-10. doi: 10.37349/etat.2022.00067. Epub 2022 Jan 14. Explor Target Antitumor Ther. 2022. PMID: 36046359 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page